Welcome to our dedicated page for Regional Health SEC filings (Ticker: RHE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Parsing Regional Health Properties’ disclosures can feel like navigating a skilled-nursing facility’s floor plan in the dark—hundreds of pages, tenant health metrics buried in footnotes, and Form 8-K updates that land without warning. If you have ever asked, “How do I track Regional Health Properties insider trading Form 4 transactions?” or “Where is the latest Regional Health Properties quarterly earnings report 10-Q filing?”, this page is built for you.
Stock Titan’s AI pinpoints what matters in every submission. Need rent coverage ratios from the annual report? Our engine highlights them inside the Regional Health Properties annual report 10-K simplified summary. Curious about executive moves? Get Regional Health Properties Form 4 insider transactions in real-time, complete with easy-to-read charts. Material event just posted? Our alert breaks down the Regional Health Properties 8-K material events explained section before the market opens.
Here’s what you’ll uncover:
- Income trends and occupancy shifts inside each Regional Health Properties earnings report filing analysis (10-Q)
- Board decisions on operator renewals in the proxy statement executive compensation filings
- Facility acquisitions, divestitures, and reimbursement updates distilled from 8-Ks
- Understanding Regional Health Properties SEC documents with AI—plain-language explanations replace dense legalese
All filings stream directly from EDGAR the moment they post, then flow through our AI for concise summaries, keyword search, and side-by-side comparisons. Stop sifting through PDFs; start making decisions faster with filings that are finally clear.
F. Scott Kellman, a director of Regional Health Properties, Inc. (RHE), filed an initial Form 3 reporting his beneficial ownership. The Form lists the date of the event as 08/14/2025 and shows zero shares of common stock owned, reported as direct ownership. The filing is signed by Mr. Kellman on 08/18/2025.
Robert M. Thornton Jr. filed an Initial Statement of Beneficial Ownership (Form 3) disclosing his relationship to Regional Health Properties, Inc. (RHEP). The filing shows Mr. Thornton is an Executive Vice President – Corporate Strategy and a director, and it reports the date of the triggering event as
Gene E. Burleson, a director of Regional Health Properties, Inc. filed an initial Form 3 disclosing beneficial ownership under Section 16. The form records the triggering event date as
Regional Health Properties, Inc. (ticker RHE) filed an Form 3 reporting initial beneficial ownership information for Mark J. Stockslager, who is listed as CFO and a director. The event date triggering the filing is 08/14/2025. The filing shows 0 shares of common stock beneficially owned, reported directly. The form is signed by Mr. Stockslager on 08/18/2025. No derivative securities, option grants, or other holdings are reported on the form.
Amendment No. 14 to a Schedule 13D filed by Charles Frischer and the Libby Frischer Family Partnership updates their disclosure regarding Common Stock of Regional Health Properties, Inc. The filing lists the issuer's principal executive office in Atlanta and references a long history of prior Schedule 13D amendments.
The filing shows Mr. Frischer beneficially owns 1,999 common shares, representing 1% of the class, while the Partnership reports 0 shares. The filers state they collectively own less than 5% of the outstanding common shares. The document identifies an event date of 08/06/2025 and is signed on 08/11/2025.
Regional Health Properties (RHE) filed an 8-K after convening a 29-Jul-25 special meeting of common shareholders focused on its pending merger with SunLink Health Systems. The sole agenda item—authority to adjourn the meeting to solicit additional votes for the merger and related share-issuance proposals—passed with 1,043,581 votes “for,” 298,162 “against,” and 13,382 abstentions (no broker non-votes), reflecting 77.2% support.
The meeting will reconvene at company headquarters on 4-Aug-25, 10:00 a.m. ET; the 20-Jun-25 record date and previously submitted proxies remain valid. Approval of the merger itself and regulatory clearances are still pending.
RHE reiterated risk factors covering integration, regulatory approvals, listing compliance, leverage and macro conditions. Its common and Series A preferred shares continue to trade OTCQB (symbols RHEP, RHEPA) following NYSE American delisting on 11-Jun-25. No earnings or operational metrics were disclosed.
FAQ
What is the current stock price of Regional Health (RHE)?
What is the market cap of Regional Health (RHE)?
